companydata.dkY-mAbs Therapeutics A/S: Financial statements 2024
CVR: 37053678
Y-mAbs Therapeutics A/S (CVR 37053678) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 74,262,634 and a net result of DKK -12,500,464 compared with DKK -27,748,840 the year before. That is an increase of 5.1% compared with the year before. Equity amounted to DKK -125,190,245. The company had 56 employees in the financial year.
- Gross Profit
- 74,262,634 kr.
- Profit/Loss
- -12,500,464 kr.
- Equity
- -125,190,245 kr.
- Total Assets
- 26,470,481 kr.
- Employees
- 56
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 74.3 mio. | -12.5 mio. | -125.2 mio. | 56 |
| 2023 | - | 70.7 mio. | -27.7 mio. | -112.7 mio. | 59 |
| 2022 | - | 82.3 mio. | -85.7 mio. | -84.9 mio. | 101 |
| 2021 | - | 67.5 mio. | -42.1 mio. | -39.3 mio. | 88 |
| 2020 | - | 82.4 mio. | -1.2 mio. | 2.8 mio. | 62 |
How creditworthy is Y-mAbs Therapeutics A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of July 31, 2024, Thomas Gad has joined the board of directors of Y-mAbs Therapeutics A/S.
As of July 31, 2024, Bo Kruse has left the board of directors of Y-mAbs Therapeutics A/S.
As of July 30, 2024, Thomas Gad has left the board of directors of Y-mAbs Therapeutics A/S.
Y-mAbs Therapeutics A/S has published its annual report for 2023. Gross profit came to DKK 70,656,043, and the net result was DKK -27,748,840.
About Y-mAbs Therapeutics A/S
Y-mAbs Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Vincent Sainte-Catherine. The company is owned by Y-mAbs Therapeutics, Inc.. The company has 24 employees. In 2025, the company reported a gross profit of DKK 29,300,371 and a net result of DKK -38,461,598 compared with DKK -12,500,464 the year before. Equity amounted to DKK -163,651,844.